Verrill’s patent attorneys specialize in assisting biotech and life science clients at every level from university research, to startups, to mid-market and large corporations. We understand the challenges of leveraging funding for product development from dynamic research programs in a competitive environment. We’re experienced in US and foreign patent prosecution, patent litigation, post-grant proceedings, opinions related to non-infringement, invalidity, freedom to operate, inventorship disputes, licensing, portfolio analysis, and competitor analysis.

        Our patent prosecutors have extensive experience dealing with patent eligibility matters and work with a wide array of technologies including the following:

        • Antibodies
        • Aptamers
        • Aquaculture
        • Biofuels
        • Cancer therapies and vaccines
        • CAR T-cells
        • Cell culture
        • Chromatography systems
        • CRISPR technology
        • Drug delivery vehicles
        • Drug formulation
        • ELISA
        • Fluorescence in situ hybridization
        • Food science and enzymes
        • Gene therapy
        • Genetic adjuvants
        • Genomics
        • Immunotherapeutics
        • Industrial chemical and biochemical processes
        • Medical diagnostics
        • Microscopy technology and image analysis
        • Modular agricultural systems
        • Nanoparticles
        • Nucleic acids
        • Nutritional biochemistry
        • Probes
        • Proteins
        • Sequencing technology
        • Small molecule pharmaceuticals
        • Spectrometry
        • Stem cells
        • Targeting of drugs and biologics
        • Test kits
        • Transgenic animals
        • Treatment of diabetes and metabolic diseases
        • Viral vectors

        Examples of how our patent attorneys have helped their biotech clients include:

        • Quickly established a patent portfolio in the competitive CAR T-cell space to support funding efforts of a biotech startup.
        • Assisted an instrumentation company in an inventorship dispute with its research collaborator, resulting in the company establishing its own patent portfolio.
        • Obtained broad patent coverage for a biologics formulations company to support its partnering efforts.
        Experience
        Successfully obtained federal, state, and local permits for multiple expansions of Maine’s only commercial landfill facility and provides ongoing compliance and regulatory support for the landfill and associated facilities.

        Firm Highlights

        Press Releases

        97 Verrill Attorneys Recognized by Best Lawyers® 2027, Including Four Named Lawyers of the Year

        AUGUSTA, Maine, BANGOR, Maine, BOSTON, Mass., PORTLAND, Maine, and WESTPORT, Conn., (August 20, 2026) – Verrill is proud to announce that 97...
        Alerts and Newsletters

        SEC’s Proposed “Reg Crypto”: What Founders Need to Know

        Startup founders and emerging-growth companies have a number of options for raising capital under the federal securities laws, including Regulation D...
        Blog

        After 45 Years, the IRS Speaks on DCAP Nondiscrimination Testing – And It’s Good News

        Employers that provide a Dependent Care Assistance Program will be pleased to learn that for the first time in 45 years, the IRS has issued guidance...
        Media Mentions

        Robert Keach Discusses Bankruptcy Auction Strategy in Law360

        Verrill attorney Robert Keach spoke with Law360 article examining the complex bankruptcy auction process that resulted in the sale of 23 summer...
        Media Mentions

        Martha Gaythwaite Featured in Portland Press Herald Coverage of Sig Sauer Trial Victory

        Verrill attorney Martha Gaythwaite was highlighted in media coverage of a federal trial in Bangor involving firearm manufacturer Sig Sauer. As...
        Media Mentions

        Law360 Quotes Robert Keach on Senate Bill Affecting Small Business Restructurings

        Verrill attorney Robert Keach was recently quoted in a Law360 article discussing federal legislation that would permanently restore the $7.5 million...
        Alerts and Newsletters

        SAFEs and Preferred Stock – Key Deal Terms Every Founder Should Know

        SAFEs Before negotiating a term sheet for preferred stock, many early-stage companies, particularly at the seed stage, first raise capital through...
        Press Releases

        Verrill Welcomes Business Restructuring and Insolvency Attorney Nimra Tariq

        BOSTON, Massachusetts – Verrill is pleased to announce that Nimra Tariq has joined the firm’s Business Restructuring and Insolvency Group as an...
        Media Mentions

        Robert Keach Provides Commentary on First Brands Restructuring in Law360

        Verrill attorney Robert Keach was quoted in the Law360 article, "First Brands' Ch. 11 Plan Revives Angst Over Admin Claims," discussing First Brands...
        Press Releases

        Verrill Welcomes Construction Attorney Cassie Dufon

        PORTLAND, Maine – Verrill is pleased to welcome Cassie Dufon to the firm’s Construction Group as an Associate, resident in the firm’s Portland...
        Press Releases

        Verrill’s Wide-Ranging Private Wealth Law Practice Recognized in 2026 Chambers and Partners High Net Worth Guide

        BANGOR and PORTLAND, Maine and BOSTON, Mass. – Verrill attorneys Kenneth P. Brier, Anya F. Endsley, Kurt E. Klebe, Mary McQuillen, Nathaniel S....
        Blog

        Update on Status of Maine Packaging EPR

        In December 2024, Verrill published a blog post, Unwrapping Maine's Gift to the Environment: A New Packaging Stewardship Program Set to Launch in...